A5001285713- Bipolar Disorder and Treatment
- Treatment of Major Depression
- Schizophrenia research and treatment
- Electroconvulsive Therapy Studies
- Tryptophan and brain disorders
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Attention Deficit Hyperactivity Disorder
- Mental Health Research Topics
- Functional Brain Connectivity Studies
- Pharmacy and Medical Practices
- Pharmacological Effects and Toxicity Studies
- Maternal Mental Health During Pregnancy and Postpartum
- Stress Responses and Cortisol
- Mental Health Treatment and Access
- Coordination Chemistry and Organometallics
- Child and Adolescent Psychosocial and Emotional Development
- Diet and metabolism studies
- Pharmaceutical Practices and Patient Outcomes
- Suicide and Self-Harm Studies
- Eating Disorders and Behaviors
- Personality Disorders and Psychopathology
- Nicotinic Acetylcholine Receptors Study
- Electrolyte and hormonal disorders
- Neuroscience and Neuropharmacology Research
- Stuttering Research and Treatment
Catholic University of Korea
2015-2024
Dr Youth Clinic
2024
Yeouido St. Mary's Hospital
2011-2023
Seoul St. Mary's Hospital
2017-2023
Kyungpook National University
2023
Jeju National University Hospital
2016
Inje University
2016
Jeonbuk National University
2016
University Health Network
2016
Soonchunhyang University
2015
Cognitive deficits in major depressive disorder (MDD) patients have been described numerous studies. However, few reports aimed to describe cognitive the remitted state of MDD and mediational effect on occupational outcome. The aim current review is synthesize literature mediating moderating effects specific domains cognition impairment among people with MDD. In addition, predictors found be vocationally important will examined. Upon examination extant literature, attention, executive...
Aims: Ghrelin is a peptide hormone that antagonizes the action of leptin and thereby thought to regulate feeding behaviour.The actions ghrelin appear be mediated by neuropeptide Y (NPY) Agouti-related protein (AGRP) system.Recent studies have suggested NPY play significant roles in pathophysiology alcoholism.The aim this study was determine whether associated with state duration abstinence individuals alcohol dependence.Methods: Fasting plasma levels were compared between 47 chronic...
Melatonin is a hormone that secreted by the pineal gland. To date, melatonin known to regulate sleep cycle controlling circadian rhythm. However, recent advances in neuroscience and molecular biology have led discovery of new actions effects melatonin. In studies, was shown antioxidant activity and, possibly, affect development Alzheimer's disease (AD). addition, has neuroprotective affects neuroplasticity, thus indicating potential antidepressant properties. present review, functions are...
This study investigated the prevalence and comorbidities of attention deficit hyperactivity disorder (ADHD) among adults children/adolescents in Korea.This used data from Korea Health Insurance Review Assessment Service collected 2008 to 2018. Study participants comprised patients with at least one diagnosis ADHD (International Statistical Classification Diseases Related Provisions, 10th revision code F90.0). Prevalence rates psychiatric were also analyzed.We identified 878,996 diagnosed...
Other SectionsAbstractINTRODUCTIONMETHODSRESULTSDISCUSSIONAcknowledgmentsConflicts of InterestAuthor ContributionsFiguresTablesReferences
In 2002, the Korean Society for Affective Disorders developed guidelines treatment of major depressive disorder (MDD), and revised it in 2006 2012. The third revision these was undertaken to reflect advances field.Using a 44-item questionnaire, an expert consensus obtained on pharmacological strategies MDD 1) without or 2) with psychotic features, 3) depression subtypes, 4) maintenance, 5) special populations, 6) choice antidepressant (AD) regarding safety adverse effects, 7)...
Objective Alzheimer’s disease (AD) is the most common type of dementia and prevalence rapidly increased as elderly population worldwide. In contemporary model AD, it regarded a continuum involving preclinical stage to severe dementia. For accurate diagnosis monitoring, objective index reflecting structural change brain needed correctly assess patient’s severity neurodegeneration independent from clinical symptoms. The main aim this paper develop random forest (RF) algorithm-based prediction...
The aim of this study was to examine the validity Korean version Hypomania Checklist-32, second revision (HCL-32-R2) in mood disorder patients.A total 454 patients who diagnosed as according Structured Clinical Interview for DSM-IV Axis I Disorders, clinician (SCID-CV) (bipolar [BD] I, n=190; BD-II, n=72; and major depressive [MDD], n=192) completed module HCL-32-R2 (KHCL-32-R2).The KHCL-32-R2 showed a three-factorial structure (eigenvalue ＞2) that accounted 43.26% variance. Factor 1 labeled...
The goal of this study was to investigate the safety and efficacy in preventing relapse a mood episode recently manic or mixed patients with bipolar I disorder stabilized aripiprazole divalproex combination.This randomized, 24-week, double-blind, placebo-controlled multicenter enrolled from 23 centers Korea. Patients who had entered 6-week open-label stabilization phase. After meeting criteria, 83 were randomly assigned placebo + treatment group for double-blind maintenance phase.During...
The Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was first published in 2002 through an expert consensus of opinion, and updated 2006, 2010, 2014. This study constitutes the fourth revision KMAP-BP.A 50-item questionnaire used to obtain experts regarding pharmacological treatment strategies various phases adult bipolar disorder six items pediatric disorder. review committee included 84 psychiatrists 43 child adolescent psychiatry experts.The preferred first-step acute...
The objective of this study was to compare recommendations the Korean Medication Algorithm Project for Bipolar Disorder 2018 (KMAP-BP 2018) with other recently published guidelines treating bipolar disorder. We reviewed a total five global treatment and compared recommendation KMAP-BP those guidelines. For initial mania, there were no significant differences across All recommended mood stabilizer (MS) or atypical antipsychotic (AAP) monotherapy combination an MS AAP as first-line strategy...